Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cenerimod single dose in healthy Japanese and Caucasian subjects
NCT04052360Phase 1Completed
- Sponsor
- Viatris
- Start
- Aug 2019
- Primary completion
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial comparing Cenerimod 4 mg with Placebo (2 arms). Primary endpoint: Area Under the Plasma Concentration-Time Curve. Started Aug 2019; status: completed.
02
Drugs
cenerimod
Beyond the preview
Go deeper on NCT04052360.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04052360.